ATE271225T1 - Verwendung von urintrypsininhibitor zur diagnose von aids - Google Patents

Verwendung von urintrypsininhibitor zur diagnose von aids

Info

Publication number
ATE271225T1
ATE271225T1 AT00902627T AT00902627T ATE271225T1 AT E271225 T1 ATE271225 T1 AT E271225T1 AT 00902627 T AT00902627 T AT 00902627T AT 00902627 T AT00902627 T AT 00902627T AT E271225 T1 ATE271225 T1 AT E271225T1
Authority
AT
Austria
Prior art keywords
trypsin inhibitor
aids
urine trypsin
diagnosing aids
diagnosing
Prior art date
Application number
AT00902627T
Other languages
English (en)
Inventor
Marina N Papuashvili
Original Assignee
Technologie Integrale Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technologie Integrale Ltd filed Critical Technologie Integrale Ltd
Application granted granted Critical
Publication of ATE271225T1 publication Critical patent/ATE271225T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • AIDS & HIV (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00902627T 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids ATE271225T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903034 1999-01-26
DE19920704A DE19920704C1 (de) 1999-01-26 1999-05-05 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS
PCT/EP2000/000522 WO2000045175A1 (en) 1999-01-26 2000-01-24 Urinary trypsin inhibitor to diagnose aids

Publications (1)

Publication Number Publication Date
ATE271225T1 true ATE271225T1 (de) 2004-07-15

Family

ID=26051490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00902627T ATE271225T1 (de) 1999-01-26 2000-01-24 Verwendung von urintrypsininhibitor zur diagnose von aids

Country Status (11)

Country Link
US (1) US6242197B1 (de)
EP (1) EP1147420B1 (de)
JP (1) JP3534703B2 (de)
AT (1) ATE271225T1 (de)
AU (1) AU770114B2 (de)
CA (1) CA2361000C (de)
DE (2) DE19920704C1 (de)
DK (1) DK1147420T3 (de)
ES (1) ES2225081T3 (de)
PT (1) PT1147420E (de)
WO (1) WO2000045175A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832155B1 (fr) * 2001-11-09 2004-07-09 Lab Francais Du Fractionnement Anticorps stimulant la production d'il-1ra
WO2005040222A1 (en) * 2003-10-16 2005-05-06 Bayer Healthcare Llc Monoclonal antibodies for detection of urinary trypsin inhibitors
AU2011230619C1 (en) 2010-03-25 2016-06-23 Oregon Health & Science University CMV glycoproteins and recombinant vectors
HUE037408T2 (hu) 2011-06-10 2018-08-28 Univ Oregon Health & Science CMV glikoproteinek és rekombináns vektorok
CA2789539A1 (en) 2011-09-12 2013-03-12 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
EP2848937A1 (de) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Verfahren zur Identifizierung neuartiger HIV-1-Immunogene
US10058604B2 (en) 2013-10-07 2018-08-28 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
EP3069730A3 (de) 2015-03-20 2017-03-15 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9925258B2 (en) 2015-10-02 2018-03-27 International Aids Vaccine Initiative Replication-competent VSV-HIV Env vaccines
US11725043B2 (en) 2020-03-05 2023-08-15 DiaMedica USA Inc. Ulinastatin polypeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
JPH05304983A (ja) * 1992-04-27 1993-11-19 Nissin Food Prod Co Ltd ヒト尿中蛋白質分解酵素阻害蛋白質の定量のための物質および定量方法

Also Published As

Publication number Publication date
DE60012140D1 (de) 2004-08-19
EP1147420A1 (de) 2001-10-24
JP3534703B2 (ja) 2004-06-07
JP2002535679A (ja) 2002-10-22
CA2361000C (en) 2009-12-22
US6242197B1 (en) 2001-06-05
DK1147420T3 (da) 2004-11-29
ES2225081T3 (es) 2005-03-16
WO2000045175A1 (en) 2000-08-03
CA2361000A1 (en) 2000-08-03
EP1147420B1 (de) 2004-07-14
PT1147420E (pt) 2004-12-31
AU2439600A (en) 2000-08-18
DE19920704C1 (de) 2000-08-31
AU770114B2 (en) 2004-02-12
DE60012140T2 (de) 2005-09-08

Similar Documents

Publication Publication Date Title
ATE271225T1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
EP1124598A4 (de) System zur diagnose von harninkontinenz
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
WO2002040634A3 (en) Expression miniarrays and uses thereof
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
AU2003214604A8 (en) Peripheral blood cell markers useful for diagnosing multiple sclerosis and methods and kits utilizing same
AU4694499A (en) Trace level detection of analytes using artificial olfactometry
ATE264618T1 (de) Behandlung von durch vielfach ungesättigten lipid-metaboliten vermittelten lungenerkrankungen und tests für epoxidhydrolase-inhibitoren
TR199800815A2 (en) S�lfonilaminokarbonasitler.
EP1461061A4 (de) Zusammensetzungen und verfahren zum nachweis und zur behandlung von krankheiten und zuständen im zusammenhang mit chemokine-rezeptoren
MA28153A1 (fr) Acides nucléiques se liant spécifiquement à la ghréline biologiquement active
DE59814473D1 (de) Wandleranordnung für teil- oder vollimplantierbare Hörgeräte
DE50207866D1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
DE10082504D2 (de) Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE60039760D1 (de) Diagnose von Restenose
FI952767L (fi) Väline antrum- ja korpuskoepalojen yhdistetyn ureaasitestin tekemiseksi maha- ja suolistosairauksien diagnosointia varten
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
ATE386935T1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür
WO2000071081A3 (en) Methods of diagnosis and treatment of meniere disease
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
EP1408808A4 (de) Verfahren zur diagnose und behandlung von herzerkrankungen
ATE220458T1 (de) Pyridinolin-quervernetzung als hinweis auf krankhafte vorgänge an periodontalen und peripheren implantaten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1147420

Country of ref document: EP

REN Ceased due to non-payment of the annual fee